n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Disease Exacerbation in 10 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This suggests that HF promoted prostate cancer cell growth is COX-2 dependent and this HF-COX-2 activation pathway can account for one reason of CAB therapy failure." | 1.35 | A new prostate cancer therapeutic approach: combination of androgen ablation with COX-2 inhibitor. ( Bao, BY; Cai, Y; Chang, C; Hsu, CL; Huang, J; Lee, YF; Li, G; Liu, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H | 1 |
| Zhang, X | 1 |
| Feng, L | 1 |
| Totoson, P | 1 |
| Maguin-Gaté, K | 1 |
| Nappey, M | 1 |
| Wendling, D | 1 |
| Demougeot, C | 1 |
| Wang, P | 1 |
| Guan, PP | 1 |
| Yu, X | 1 |
| Zhang, LC | 1 |
| Su, YN | 1 |
| Wang, ZY | 1 |
| Zeng, Q | 1 |
| McCauley, LK | 1 |
| Wang, CY | 1 |
| Nakata, H | 1 |
| Uemura, Y | 1 |
| Kobayashi, M | 1 |
| Harada, R | 1 |
| Taguchi, H | 1 |
| Zhi, H | 1 |
| Wang, L | 1 |
| Zhang, J | 1 |
| Zhou, C | 1 |
| Ding, F | 1 |
| Luo, A | 1 |
| Wu, M | 1 |
| Zhan, Q | 1 |
| Liu, Z | 1 |
| Español, AJ | 1 |
| de la Torre, E | 1 |
| Fiszman, GL | 1 |
| Sales, ME | 1 |
| Bhave, VS | 1 |
| Donthamsetty, S | 1 |
| Latendresse, JR | 1 |
| Mehendale, HM | 1 |
| Cai, Y | 1 |
| Lee, YF | 1 |
| Li, G | 1 |
| Liu, S | 1 |
| Bao, BY | 1 |
| Huang, J | 1 |
| Hsu, CL | 1 |
| Chang, C | 1 |
| Di Popolo, A | 1 |
| Memoli, A | 1 |
| Apicella, A | 1 |
| Tuccillo, C | 1 |
| di Palma, A | 1 |
| Ricchi, P | 1 |
| Acquaviva, AM | 1 |
| Zarrilli, R | 1 |
10 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Disease Exacerbation
| Article | Year |
|---|---|
Ghrelin Regulates Cyclooxygenase-2 Expression and Promotes Gastric Cancer Cell Progression.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Computational Biology; Cyclooxygenase 2; Cyclooxygenase | 2021 |
Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation.
Topics: Acetylcholine; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Biomarkers; Chemokines; Cycl | 2016 |
Prostaglandin I₂ Attenuates Prostaglandin E₂-Stimulated Expression of Interferon γ in a β-Amyloid Protein- and NF-κB-Dependent Mechanism.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Brain; Cell Nucleus; Dinoprostone; Di | 2016 |
Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression.
Topics: Animals; Anoikis; Apoptosis; Blotting, Northern; Blotting, Western; Carcinoma, Squamous Cell; Cell D | 2002 |
Cyclooxygenase-2 inhibitor NS-398 suppresses cell growth and constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
Topics: Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoproston | 2003 |
Significance of COX-2 expression in human esophageal squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Disease Progres | 2006 |
Role of non-neuronal cholinergic system in breast cancer progression.
Topics: Animals; Arginase; Carbachol; Cell Line, Tumor; Cholinergic Agonists; Cyclooxygenase Inhibitors; Dis | 2007 |
Inhibition of cyclooxygenase-2 aggravates secretory phospholipase A2-mediated progression of acute liver injury.
Topics: Acute Disease; Alanine Transaminase; Animals; Blotting, Western; Carbon Radioisotopes; Carbon Tetrac | 2008 |
A new prostate cancer therapeutic approach: combination of androgen ablation with COX-2 inhibitor.
Topics: Androgen Antagonists; Androgens; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemothera | 2008 |
IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Apoptosis; Caco-2 Cells; Cell Divis | 2000 |